These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB. Kimura K, Teranishi S, Fukuda K, Kawamoto K, Nishida T. Invest Ophthalmol Vis Sci; 2008 Feb 21; 49(2):565-71. PubMed ID: 18235000 [Abstract] [Full Text] [Related]
9. Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells. Tanaka H, Fukuda K, Ishida W, Harada Y, Sumi T, Fukushima A. Br J Ophthalmol; 2013 Jul 21; 97(7):912-6. PubMed ID: 23603753 [Abstract] [Full Text] [Related]
10. Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Mandell KJ, Berglin L, Severson EA, Edelhauser HF, Parkos CA. Invest Ophthalmol Vis Sci; 2007 Sep 21; 48(9):3928-36. PubMed ID: 17724169 [Abstract] [Full Text] [Related]
11. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor. Kimura K, Teranishi S, Kawamoto K, Nishida T. Exp Eye Res; 2010 Feb 21; 90(2):337-43. PubMed ID: 19944686 [Abstract] [Full Text] [Related]
13. A microengineered human corneal epithelium-on-a-chip for eye drops mass transport evaluation. Bennet D, Estlack Z, Reid T, Kim J. Lab Chip; 2018 May 29; 18(11):1539-1551. PubMed ID: 29736535 [Abstract] [Full Text] [Related]
20. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by keratinocyte growth factor. Teranishi S, Kimura K, Kawamoto K, Nishida T. Invest Ophthalmol Vis Sci; 2008 Jun 29; 49(6):2432-7. PubMed ID: 18362114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]